Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial.

[1]  C. Bai,et al.  Efficacy of doxycycline versus azithromycin for the treatment of rectal chlamydia: a systematic review and meta-analysis. , 2021, The Journal of antimicrobial chemotherapy.

[2]  K. Workowski,et al.  Sexually Transmitted Infections Treatment Guidelines, 2021 , 2021, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[3]  A. McNulty,et al.  Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis. , 2021, The New England journal of medicine.

[4]  Michael R. Wierzbicki,et al.  DoDoxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men who have Sex with Men: A Randomized Controlled Trial. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  C. Hoebe,et al.  Viable bacterial load is key to azithromycin treatment failure in rectally Chlamydia trachomatis infected women (FemCure). , 2019, The Journal of infectious diseases.

[6]  M. Golden,et al.  Recurrent/intermittent vaginal and rectal chlamydial infection following treatment: a prospective cohort study among female STD clinic patients. , 2019, The Journal of infectious diseases.

[7]  C. Hoebe,et al.  A longitudinal study to investigate previous Chlamydia trachomatis infection as a risk factor for subsequent anorectal infection in men who have sex with men (MSM) and women visiting STI clinics in the Netherlands , 2019, Epidemiology and Infection.

[8]  N. Low,et al.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 , 2019, Bulletin of the World Health Organization.

[9]  M. Krêt,et al.  Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study) , 2019, Medicine.

[10]  C. Hoebe,et al.  Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure) , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Nastassya L Chandra,et al.  Detection of Chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis , 2018, Sexually Transmitted Infections.

[12]  L. March,et al.  Chlamyweb Study II: a randomised controlled trial (RCT) of an online offer of home-based Chlamydia trachomatis sampling in France , 2017, Sexually Transmitted Infections.

[13]  J. Boman,et al.  Rectal chlamydia – should screening be recommended in women? , 2017, International journal of STD & AIDS.

[14]  Johannes A Bogaards,et al.  What explains anorectal chlamydia infection in women? Implications of a mathematical model for test and treatment strategies , 2016, Sexually Transmitted Infections.

[15]  C. Hoebe,et al.  Viability-PCR Shows That NAAT Detects a High Proportion of DNA from Non-Viable Chlamydia trachomatis , 2016, PloS one.

[16]  J. Hocking,et al.  Higher organism load associated with failure of azithromycin to treat rectal chlamydia , 2016, Epidemiology and Infection.

[17]  M. Unemo,et al.  2015 European guideline on the management of Chlamydia trachomatis infections , 2010, International journal of STD & AIDS.

[18]  C. Bébéar,et al.  Comparison of three real-time PCR assays for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in young pregnant women. , 2015, Diagnostic microbiology and infectious disease.

[19]  R. Rank,et al.  An alternative scenario to explain rectal positivity in Chlamydia-infected individuals. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Hocking,et al.  The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. , 2015, The Journal of antimicrobial chemotherapy.

[21]  R. Guy,et al.  Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Challenor,et al.  Rectal Chlamydia in heterosexual women: more questions than answers , 2014, International journal of STD & AIDS.

[23]  R. Rank,et al.  Hidden in Plain Sight: Chlamydial Gastrointestinal Infection and Its Relevance to Persistence in Human Genital Infection , 2014, Infection and Immunity.

[24]  A. Goudeau,et al.  Interest of simultaneous Chlamydia trachomatis and Neisseria gonorrhoeae screening at the time of preabortion consultation. , 2012, Contraception.

[25]  J. Warszawski,et al.  Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France , 2010, Sexually Transmitted Infections.

[26]  S. Garland,et al.  Development and Evaluation of an ompA Quantitative Real-Time PCR Assay for Chlamydia trachomatis Serovar Determination , 2010, Journal of Clinical Microbiology.

[27]  A. Blackwell,et al.  Rectal Chlamydia trachomatis infection in women. Is it overlooked? , 2010, International journal of STD & AIDS.

[28]  M. Unemo,et al.  European Guideline for the Management of Chlamydia Trachomatis Infections , 2022 .

[29]  B. Dutilh,et al.  Evaluation of molecular typing for epidemiological study of Chlamydia trachomatis genital infections , 1993, Journal of clinical microbiology.